Connect:        


All Releases
View Summary Intellipharmaceutics Announces Third Quarter 2013 Results
Oct 1, 2013
PDF 27.8 KB Add to Briefcase
View Summary Intellipharmaceutics Closes Public Offering for US$3.1 Million
Jul 31, 2013
PDF 16.0 KB Add to Briefcase
View Summary Intellipharmaceutics Announces Pricing of Public Offering of Common Shares and Warrants
Jul 26, 2013
PDF 15.5 KB Add to Briefcase
View Summary Intellipharmaceutics Announces Proposed Public Offering of Units of Common Shares and Warrants
Jul 26, 2013
PDF 15.3 KB Add to Briefcase
  Intellipharmaceutics Updates Developments on its Rexista™ Oxycodone Technology
Jul 15, 2013
PDF 55.6 KB Add to Briefcase
View Summary Intellipharmaceutics Announces Second Quarter 2013 Results
Jul 2, 2013
PDF 28.9 KB Add to Briefcase
View Summary Intellipharmaceutics Announces Webcast of Presentation at the 12th Annual Needham Healthcare Conference
Apr 24, 2013
PDF 14.4 KB Add to Briefcase
View Summary Intellipharmaceutics Announces First Quarter 2013 Results
Apr 3, 2013
PDF 26.9 KB Add to Briefcase
View Summary Intellipharmaceutics Closes US$3.1 Million Registered Direct Offering of Units
Mar 25, 2013
PDF 16.2 KB Add to Briefcase
View Summary Intellipharmaceutics to Raise US$3.1 Million
Mar 19, 2013
PDF 16.1 KB Add to Briefcase
View Summary Intellipharmaceutics Announces Update on Its Generic Versions of Keppra XR(R) and Pristiq(R)
Mar 13, 2013
PDF 14.9 KB Add to Briefcase
View Summary Intellipharmaceutics Announces 2012 Year End Results
Jan 31, 2013
PDF 30.1 KB Add to Briefcase
View Summary Intellipharmaceutics Closes US$1.5 Million Convertible Debenture Financing
Jan 10, 2013
PDF 15.3 KB Add to Briefcase
View Summary Intellipharmaceutics Announces Proposed Convertible Debenture Financing
Jan 7, 2013
PDF 15.6 KB Add to Briefcase
View Summary Intellipharmaceutics Announces Results of Initial Phase I Clinical Trial of Controlled-Release Pregabalin and Product Updates
Nov 27, 2012
PDF 16.5 KB Add to Briefcase
View Summary Intellipharmaceutics to Present at the 24th Annual Piper Jaffray Healthcare Conference
Nov 21, 2012
PDF 15.0 KB Add to Briefcase
View Summary Intellipharmaceutics Announces Third Quarter 2012 Results
Oct 2, 2012
PDF 29.9 KB Add to Briefcase
View Summary Intellipharmaceutics Achieves a 2012 Goal by Filing Two ANDAs -- Generic Forms of Keppra XR(R) and Pristiq(R)
Sep 5, 2012
PDF 15.0 KB Add to Briefcase
View Summary Intellipharmaceutics Settles Patent Litigation With AstraZeneca Concerning Generic Seroquel XR(R)
Jul 31, 2012
PDF 14.9 KB Add to Briefcase
View Summary Intellipharmaceutics International Inc. to Webcast, Live, at RetailInvestorConferences.com on July 12th
Jul 10, 2012
PDF 16.6 KB Add to Briefcase
Showing 81-100 of 159 Page: 1 ... 3 4 5 6 7 8  Previous 20 | Next 20
=add release to Briefcase